EXACT Therapeutics AS

OB:EXTX 주식 보고서

시가총액: NOK 182.9m

EXACT Therapeutics 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Per Walday

최고 경영자

NOK 2.8m

총 보상

CEO 급여 비율80.2%
CEO 임기2.4yrs
CEO 소유권n/a
경영진 평균 재임 기간2.3yrs
이사회 평균 재임 기간5.1yrs

최근 관리 업데이트

Recent updates

Here's Why We're Watching EXACT Therapeutics' (OB:EXTX) Cash Burn Situation

Aug 09
Here's Why We're Watching EXACT Therapeutics' (OB:EXTX) Cash Burn Situation

Is EXACT Therapeutics (OB:EXTX) In A Good Position To Invest In Growth?

Apr 20
Is EXACT Therapeutics (OB:EXTX) In A Good Position To Invest In Growth?

We Think EXACT Therapeutics (OB:EXTX) Can Afford To Drive Business Growth

Sep 07
We Think EXACT Therapeutics (OB:EXTX) Can Afford To Drive Business Growth

We're Hopeful That EXACT Therapeutics (OB:EXTX) Will Use Its Cash Wisely

May 06
We're Hopeful That EXACT Therapeutics (OB:EXTX) Will Use Its Cash Wisely

Here's Why We're Watching EXACT Therapeutics' (OB:EXTX) Cash Burn Situation

Dec 30
Here's Why We're Watching EXACT Therapeutics' (OB:EXTX) Cash Burn Situation

Companies Like EXACT Therapeutics (OB:EXTX) Are In A Position To Invest In Growth

Sep 15
Companies Like EXACT Therapeutics (OB:EXTX) Are In A Position To Invest In Growth

EXACT Therapeutics (OB:EXTX) Is In A Good Position To Deliver On Growth Plans

Jan 31
EXACT Therapeutics (OB:EXTX) Is In A Good Position To Deliver On Growth Plans

We Think EXACT Therapeutics (OB:EXTX) Can Afford To Drive Business Growth

Aug 21
We Think EXACT Therapeutics (OB:EXTX) Can Afford To Drive Business Growth

We're Not Very Worried About EXACT Therapeutics' (OB:EXTX) Cash Burn Rate

May 21
We're Not Very Worried About EXACT Therapeutics' (OB:EXTX) Cash Burn Rate

CEO 보상 분석

Per Walday 의 보수는 EXACT Therapeutics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

-NOK 55m

Mar 31 2024n/an/a

-NOK 52m

Dec 31 2023NOK 3mNOK 2m

-NOK 48m

Sep 30 2023n/an/a

-NOK 42m

Jun 30 2023n/an/a

-NOK 36m

Mar 31 2023n/an/a

-NOK 38m

Dec 31 2022NOK 2mNOK 1m

-NOK 40m

보상 대 시장: Per 의 총 보상 ($USD 255.78K )은 Norwegian 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 300.00K ).

보상과 수익: 회사가 수익성이 없는 동안 Per 의 보상이 증가했습니다.

CEO

Per Walday (64 yo)

2.4yrs

테뉴어

NOK 2,833,302

보상

Dr. Per Walday, Ph D., has been the Chief Executive Officer at PCI Biotech AS since 2008. He serves as Chief Executive Officer at EXACT Therapeutics AS since June 5, 2022.Dr. Walday had been the Chief Exe...

리더십 팀

이름위치테뉴어보상소유권
Per Walday
Chief Executive Officer2.4yrsNOK 2.83m데이터 없음
Masha Paule Nathalie Stromme
Vice-Chair of the Board9.8yrsNOK 445.00k데이터 없음
Svein Kvåle
Co Founder & COOno dataNOK 1.65m9.43%
NOK 17.2m
John Edminson
Chief Financial Officer2.1yrsNOK 2.02m데이터 없음
Amir Snapir
Chief Medical Officer2.2yrsNOK 2.66m데이터 없음
Caspar Foghsgaard
Chief Business Officerless than a yearNOK 250.00k데이터 없음
Per Sontum
Founderno dataNOK 2.49m5.99%
NOK 11.0m
Ragnar Bendicksen
Vice President of Technology2.6yrs데이터 없음데이터 없음

2.3yrs

평균 재임 기간

경험이 풍부한 관리: EXTX 의 관리팀은 경험 ( 2.3 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Masha Paule Nathalie Stromme
Vice-Chair of the Board9.8yrsNOK 445.00k데이터 없음
William Castell
Director6.8yrsNOK 275.00k1.05%
NOK 1.9m
Anders Wold
Chair of the Board2.9yrsNOK 510.00k데이터 없음
Ann-Tove Kongsnes
Director3.4yrsNOK 260.00k데이터 없음

5.1yrs

평균 재임 기간

경험이 풍부한 이사회: EXTX 의 이사회는 경험(평균 재직 기간 5.1 년)으로 간주됩니다.